Literature DB >> 29331391

microRNA-mediated regulation of splicing factors SRSF1, SRSF2 and hnRNP A1 in context of their alternatively spliced 3'UTRs.

Elżbieta Sokół1, Hanna Kędzierska1, Alicja Czubaty2, Beata Rybicka1, Katarzyna Rodzik1, Zbigniew Tański3, Joanna Bogusławska4, Agnieszka Piekiełko-Witkowska5.   

Abstract

SRSF1, SRSF2 and hnRNP A1 are splicing factors that regulate the expression of oncogenes and tumor suppressors. SRSF1 and SRSF2 contribute to the carcinogenesis in the kidney. Despite their importance, the mechanisms regulating their expression in cancer are not entirely understood. Here, we investigated the microRNA-mediated regulation of SRSF1, SRSF2 and hnRNP A1 in renal cancer. The expression of microRNAs predicted to target SRSF1, SRSF2 and hnRNP A1 was disturbed in renal tumors compared with controls. Using qPCR, Western blot/ICC and luciferase reporter system assays we identified microRNAs that contribute to the regulation of expression of SRSF1 (miR-10b-5p, miR-203a-3p), SRSF2 (miR-183-5p, miR-200c-3p), and hnRNP A1 (miR-135a-5p, miR-149-5p). Silencing of SRSF1 and SRSF2 enhanced the expression of their targeting microRNAs. miR-183-5p and miR-200c-3p affected the expression of SRSF2-target genes, TNFRSF1B, TNFRSF9, CRADD and TP53. 3'UTR variants of SRSF1 and SRSF2 differed by the presence of miRNA-binding sites. In conclusion, we identified a group of microRNAs that contribute to the regulation of expression of SRSF1, SRSF2 and hnRNP A1. The microRNAs targeting SRSF1 and SRSF2 are involved in a regulatory feedback loop. microRNAs miR-183-5p and miR-200c-3p that target SRSF2, affect the expression of genes involved in apoptotic regulation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3′UTR; Renal cancer; SRSF1; SRSF2; hnRNP A1; microRNA

Mesh:

Substances:

Year:  2018        PMID: 29331391     DOI: 10.1016/j.yexcr.2018.01.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Differential expression profile of plasma exosomal microRNAs in acute type A aortic dissection with acute lung injury.

Authors:  Chiyuan Zhang; Hui Bai; Lei Zhang; Yanfeng Zhang; Xuliang Chen; Ruizheng Shi; Guogang Zhang; Qian Xu; Guoqiang Lin
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

2.  Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus.

Authors:  Takayuki Katsuyama; Ignacio Juarez Martin-Delgado; Suzanne M Krishfield; Vasileios C Kyttaris; Vaishali R Moulton
Journal:  Rheumatology (Oxford)       Date:  2020-08-01       Impact factor: 7.580

3.  Splicing factor SRSF1 limits IFN-γ production via RhoH and ameliorates experimental nephritis.

Authors:  Takayuki Katsuyama; Hao Li; Suzanne M Krishfield; Vasileios C Kyttaris; Vaishali R Moulton
Journal:  Rheumatology (Oxford)       Date:  2021-01-05       Impact factor: 7.580

Review 4.  The RNA binding protein SRSF1 is a master switch of gene expression and regulation in the immune system.

Authors:  Sean Paz; Anastasia Ritchie; Christopher Mauer; Massimo Caputi
Journal:  Cytokine Growth Factor Rev       Date:  2020-11-02       Impact factor: 7.638

Review 5.  The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer.

Authors:  Andrea Cerasuolo; Luigi Buonaguro; Franco M Buonaguro; Maria Lina Tornesello
Journal:  Front Cell Dev Biol       Date:  2020-06-12

Review 6.  Noncoding RNAs regulate alternative splicing in Cancer.

Authors:  Yunze Liu; Xin Liu; Changwei Lin; Xianhong Jia; Hongmei Zhu; Jun Song; Yi Zhang
Journal:  J Exp Clin Cancer Res       Date:  2021-01-06

7.  Alternative splicing and cancer: a systematic review.

Authors:  Yuanjiao Zhang; Jinjun Qian; Chunyan Gu; Ye Yang
Journal:  Signal Transduct Target Ther       Date:  2021-02-24

Review 8.  miRNA-Based Regulation of Alternative RNA Splicing in Metazoans.

Authors:  Anna L Schorr; Marco Mangone
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 9.  Nuclear mRNA Quality Control and Cytoplasmic NMD Are Linked by the Guard Proteins Gbp2 and Hrb1.

Authors:  Yen-Yun Lu; Heike Krebber
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

10.  Transcription Factor and miRNA Interplays Can Manifest the Survival of ccRCC Patients.

Authors:  Shijie Qin; Xuejia Shi; Canbiao Wang; Ping Jin; Fei Ma
Journal:  Cancers (Basel)       Date:  2019-10-28       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.